Pharmacy
News
NICE rejects obinutuzumab for CLL
Credit: Linda Bartlett In a new draft guidance, the UK’s National Institute for Health and Care Excellence (NICE) has said it cannot recommend...
Conference Coverage
FDA approves cancer drugs faster, study shows
MADRID—The US Food and Drug Administration (FDA) tends to approve cancer drugs faster than Health Canada and the European Medicines Agency (EMA),...
News
Blood testing system wins marketing authorization in US
Credit: Juan D.
News
FDA approves 30-day pack of anticoagulant
Credit: NHS The US Food and Drug Administration (FDA) has approved the Xarelto Starter Pack™ for the treatment of deep vein thrombosis (DVT) and/...
News
Idelalisib approved to treat CLL, FL in EU
The European Commission has granted marketing authorization for the PI3K delta inhibitor idelalisib (Zydelig) to treat chronic lymphocytic...
News
FDA approves treatment for kids with hemophilia B
The US Food and Drug Administration (FDA) has approved a recombinant factor IX product (Rixubis) for use in children with hemophilia B. Rixubis...
News
FDA approves new treatment for PI
Credit: Baxter The US Food and Drug Administration (FDA) has approved a subcutaneous immune globulin product for use in adults with primary...
News
Heparin lot recalled due to particulate
Hospira Inc.
News
Discovery could lead to better proteasome inhibitors
showing multiple myeloma A newly discovered mechanism has paved the way for the next generation of proteasome inhibitors, according to a paper...
News
NICE recommends eculizumab for aHUS despite cost
Credit: Globovision The UK’s National Institute for Health and Care Excellence (NICE) has issued a draft guidance recommending eculizumab (...
News
Health Canada approves dabigatran for VTE
Credit: Kevin MacKenzie Health Canada has approved dabigatran etexilate (Pradaxa) for the treatment and prevention of venous thromboembolism (VTE...